ArticleBMC public health2026
Understanding the role of family social support in the medication adherence to hypertension treatment in Cambodia.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Psychosocial Support as a Multidisciplinary Asset in Hypertension Care: A Systematic Review of Medication Adherence, Blood Pressure Outcomes, and Social Context Exposures.Journal of multidisciplinary healthcare · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe prevalence of hypertension (HTN) of adults aged ≥ 40 years in Cambodia was high (35.2%) in 2020 and only one-third achieved well-control. Effective HTN management strategies are needed but with focus on some key potential factors related to the poor adherence to medication treatment. Social support, especially from family members, is considered as a potential factor determining medication adherence; however, evidence remains inconsistent with limited research conducted in Asia. Therefore, we assessed the role of social support on HTN medication adherence in Cambodia to get a better understanding of the role of social support from family members in HTN management.
methodsWe performed a population-based survey in 2020 among individuals aged ≥ 40 years and included 948 patients who were in-treatment in this study. Further key information was collected on adherence using the Medication Adherence Self-Report Scale (MARS-5) and family social support with eight-item modified Medical Outcomes Study Social Support (mMOS-SS) scale. Descriptive statistics were used to present the basic characteristics of the respondents. Chi-square test was used for the bivariate analysis of factors for medication adherence. Multiple logistic regression was used to assess the association between family social support and HTN medication adherence while controlling for some potential covariates.
resultsAmong the 948 study participants, 43.5% reported non-adherence and 56.5% reported adherence to HTN treatment. For family social support, 19.7% reported poor level, 31.3% reported fair level, and 49.9% reported good level of support. Of those with adherence to HTN treatment, 29.2% had fair level of family social support, and 54.1% had good level of family social support. Unadjusted odd ratios (OR) from the univariate analysis showed a significant association between HTN medication adherence and level of social support (P = 0.001). After controlling for covariates, having a good level of family social support increased the rate of HTN medication adherence by two-fold (AOR = 2.16, 95%CI = 1.49-3.14) compared to poor level.
conclusionsThe role of social support from family members was very positive in enhancing medication adherence among patients with HTN in Cambodia. Potential strategic interventions should include focus on establishing an intervention involving family members to provide support for HTN treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.